The Leadership Team at Evgen Pharma is responsible for setting the strategic direction and vision of the company while overseeing the development of SFX-01 and other potential treatments. They collaborate on clinical development plans, business strategies, and stakeholder engagement to advance innovative therapies for cancer and neurological conditions. By leveraging their diverse expertise, the team aims to drive the company’s growth and ensure successful outcomes in clinical trials.
View all